FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1104-1105 April 20, 1995 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pauker, S. G.

To the Editor: The commentary in the Clinical Problem-Solving article on recurrent pulmonary emboli (Dec. 1 issue)¹ states that there have been no controlled trials of the placement of inferior-vena-caval filters to treat thromboembolism and includes the pejorative statement that physicians "shudder at the thought" of having a filter permanently located in the inferior vena cava. For patients who cannot receive anticoagulant therapy for pulmonary embolism, it is unlikely that a randomized, controlled trial of mechanical protection by a vena-caval filter as compared with no treatment could be conducted, since the original study by Barritt and Jordan of the effectiveness . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.